ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,767 | -8.1% | 43,086 | 0.0% | 0.00% | – |
Q2 2023 | $69,368 | -35.3% | 43,086 | +16.5% | 0.00% | – |
Q1 2023 | $107,280 | -11.6% | 36,993 | 0.0% | 0.00% | – |
Q4 2022 | $121,337 | -13.7% | 36,993 | -0.6% | 0.00% | – |
Q3 2022 | $140,639 | -51.4% | 37,206 | +0.1% | 0.00% | – |
Q2 2022 | $289,624 | -11.9% | 37,179 | +5.1% | 0.00% | – |
Q1 2022 | $328,662 | -52.4% | 35,378 | -19.2% | 0.00% | – |
Q4 2021 | $690,000 | -11.1% | 43,789 | +1.0% | 0.00% | -100.0% |
Q3 2021 | $776,000 | +7.2% | 43,352 | -6.9% | 0.00% | 0.0% |
Q2 2021 | $724,000 | +11.6% | 46,576 | +3.1% | 0.00% | 0.0% |
Q1 2021 | $649,000 | -26.2% | 45,173 | +0.8% | 0.00% | 0.0% |
Q4 2020 | $880,000 | +65.1% | 44,818 | +9.1% | 0.00% | 0.0% |
Q3 2020 | $533,000 | +12.0% | 41,092 | +19.4% | 0.00% | – |
Q2 2020 | $476,000 | +68.2% | 34,408 | +3.4% | 0.00% | – |
Q1 2020 | $283,000 | -44.4% | 33,284 | +7.6% | 0.00% | -100.0% |
Q4 2019 | $509,000 | +21.5% | 30,930 | -0.6% | 0.00% | – |
Q3 2019 | $419,000 | -24.8% | 31,129 | +12.3% | 0.00% | -100.0% |
Q2 2019 | $557,000 | -48.7% | 27,713 | +1.5% | 0.00% | 0.0% |
Q1 2019 | $1,085,000 | +22.2% | 27,301 | +6.8% | 0.00% | 0.0% |
Q4 2018 | $888,000 | -21.1% | 25,557 | -6.1% | 0.00% | 0.0% |
Q3 2018 | $1,126,000 | +2.3% | 27,225 | -9.2% | 0.00% | 0.0% |
Q2 2018 | $1,101,000 | +15.3% | 29,969 | +22.3% | 0.00% | 0.0% |
Q1 2018 | $955,000 | +144.2% | 24,505 | +13.3% | 0.00% | – |
Q4 2017 | $391,000 | +16.0% | 21,624 | +6.5% | 0.00% | – |
Q3 2017 | $337,000 | +18.2% | 20,298 | -0.4% | 0.00% | – |
Q2 2017 | $285,000 | -27.1% | 20,377 | +7.2% | 0.00% | – |
Q1 2017 | $391,000 | +67.1% | 19,008 | +15.5% | 0.00% | – |
Q4 2016 | $234,000 | -33.5% | 16,456 | +0.1% | 0.00% | -100.0% |
Q3 2016 | $352,000 | -4.9% | 16,435 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $370,000 | +69.7% | 16,420 | +41.7% | 0.00% | – |
Q1 2016 | $218,000 | -27.3% | 11,587 | +2.0% | 0.00% | – |
Q4 2015 | $300,000 | -15.0% | 11,365 | +1.3% | 0.00% | – |
Q3 2015 | $353,000 | -30.1% | 11,219 | +17.1% | 0.00% | -100.0% |
Q2 2015 | $505,000 | +343.0% | 9,583 | +249.6% | 0.00% | – |
Q1 2015 | $114,000 | – | 2,741 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
Baupost Group | 8,123,616 | $26,645 | 0.44% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |